Mast Therapeutics Inc (fka MSTX)

[Rhodey Red]

$2.00 in 2-3 months is certainly ambitious. We would need some serious trial data/huge new analyst Price Targets or partnership/gov't funding news for that sort of move. I see a very plausible 75% move by year end if the trial data plays out as expected.